PhRMA

pharama | November 14, 2016

Today, there are more than 30 million Americans suffering from type 1 or type 2 diabetes. Roughly 5 percent of patients have type 1 and 90 to 95 percent suffer from type 2, highlighting the complexity of the disease. Because diabetes is the seventh leading cause of death in the United States, the need for innovative treatments and therapies is greater than it ever has been. America’s biopharmaceutical companies are committed to developing new and innovative medicines for patients in need. And to...

Pharama | November 15, 2016

The Pharmaceutical Research and Manufacturers of America (PhRMA) today announced that Robert Zirkelbach has been named executive vice president of public affairs. Zirkelbach assumes the responsibilities of Josephine Martin, who announced her intent to pursue new opportunities....

Pharama | November 29, 2016

Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO, Stephen J. Ubl, issued the following statement: “PhRMA congratulates Chairman Tom Price, M.D. on his nomination as Secretary of Health and Human Services. His vast health care experience and knowledge will be a great asset to the Agency. PhRMA also congratulates Seema Verma on her nomination to lead the Center for Medicare and Medicaid Services. We look forward to working with Dr. Price and Ms. Verma in their new rol...

Pharmaceutical | November 30, 2016

Pharmaceutical Research and Manufacturers of America (PhRMA) president and CEO Stephen J. Ubl issued the following statement following the passage of the 21st Century Cures Act in the House of Representatives: “PhRMA applauds the House of Representatives for passing the bipartisan 21st Century Cures Act to improve the discovery and development of new medicines for patients. The legislation includes pro-patient, science-based reforms which enhance the competitive market for biopharmaceuticals and...